
INFU Valuation
InfuSystem Holdings Inc
- Overview
- Forecast
- Valuation
- Earnings
INFU Relative Valuation
INFU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INFU is overvalued; if below, it's undervalued.
Historical Valuation
InfuSystem Holdings Inc (INFU) is now in the Fair zone, suggesting that its current forward PE ratio of 36.42 is considered Fairly compared with the five-year average of 81.03. The fair price of InfuSystem Holdings Inc (INFU) is between 1.94 to 20.00 according to relative valuation methord.
Relative Value
Fair Zone
1.94-20.00
Current Price:6.01
Fair
36.42
PE
1Y
3Y
5Y
Trailing
Forward
5.53
EV/EBITDA
InfuSystem Holdings Inc. (INFU) has a current EV/EBITDA of 5.53. The 5-year average EV/EBITDA is 10.10. The thresholds are as follows: Strongly Undervalued below 4.13, Undervalued between 4.13 and 7.11, Fairly Valued between 13.08 and 7.11, Overvalued between 13.08 and 16.07, and Strongly Overvalued above 16.07. The current Forward EV/EBITDA of 5.53 falls within the Undervalued range.
20.54
EV/EBIT
InfuSystem Holdings Inc. (INFU) has a current EV/EBIT of 20.54. The 5-year average EV/EBIT is 47.00. The thresholds are as follows: Strongly Undervalued below -12.31, Undervalued between -12.31 and 17.35, Fairly Valued between 76.66 and 17.35, Overvalued between 76.66 and 106.32, and Strongly Overvalued above 106.32. The current Forward EV/EBIT of 20.54 falls within the Historic Trend Line -Fairly Valued range.
0.83
PS
InfuSystem Holdings Inc. (INFU) has a current PS of 0.83. The 5-year average PS is 1.90. The thresholds are as follows: Strongly Undervalued below 0.12, Undervalued between 0.12 and 1.01, Fairly Valued between 2.79 and 1.01, Overvalued between 2.79 and 3.68, and Strongly Overvalued above 3.68. The current Forward PS of 0.83 falls within the Undervalued range.
4.96
P/OCF
InfuSystem Holdings Inc. (INFU) has a current P/OCF of 4.96. The 5-year average P/OCF is 10.56. The thresholds are as follows: Strongly Undervalued below 1.32, Undervalued between 1.32 and 5.94, Fairly Valued between 15.17 and 5.94, Overvalued between 15.17 and 19.79, and Strongly Overvalued above 19.79. The current Forward P/OCF of 4.96 falls within the Undervalued range.
17.74
P/FCF
InfuSystem Holdings Inc. (INFU) has a current P/FCF of 17.74. The 5-year average P/FCF is 30.04. The thresholds are as follows: Strongly Undervalued below -161.74, Undervalued between -161.74 and -65.85, Fairly Valued between 125.93 and -65.85, Overvalued between 125.93 and 221.82, and Strongly Overvalued above 221.82. The current Forward P/FCF of 17.74 falls within the Historic Trend Line -Fairly Valued range.
InfuSystem Holdings Inc (INFU) has a current Price-to-Book (P/B) ratio of 2.29. Compared to its 3-year average P/B ratio of 3.36 , the current P/B ratio is approximately -32.00% higher. Relative to its 5-year average P/B ratio of 5.14, the current P/B ratio is about -55.50% higher. InfuSystem Holdings Inc (INFU) has a Forward Free Cash Flow (FCF) yield of approximately 1.85%. Compared to its 3-year average FCF yield of 0.15%, the current FCF yield is approximately 1110.84% lower. Relative to its 5-year average FCF yield of 0.47% , the current FCF yield is about 291.41% lower.
2.29
P/B
Median3y
3.36
Median5y
5.14
1.85
FCF Yield
Median3y
0.15
Median5y
0.47
Competitors Valuation Multiple
The average P/S ratio for INFU's competitors is 0.30, providing a benchmark for relative valuation. InfuSystem Holdings Inc Corp (INFU) exhibits a P/S ratio of 0.83, which is 176.53% above the industry average. Given its robust revenue growth of 8.50%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of INFU decreased by 12.90% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 25.72 to 40.25.
The secondary factor is the Revenue Growth, contributed 8.50%to the performance.
Overall, the performance of INFU in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

GLSI
Greenwich Lifesciences Inc
11.570
USD
+0.70%

BHR
Braemar Hotels & Resorts Inc
2.380
USD
-0.42%

NEGG
Newegg Commerce Inc
34.310
USD
+11.72%

ACTU
Actuate Therapeutics Inc
7.260
USD
+3.86%

JYNT
Joint Corp
11.360
USD
+0.26%

BDSX
Biodesix Inc
0.446
USD
+6.70%

LYEL
Lyell Immunopharma Inc
12.420
USD
+19.31%

VXRT
Vaxart Inc
0
USD
-33.44%

LXEO
Lexeo Therapeutics Inc
4.130
USD
+12.53%

ALEC
Alector Inc
1.760
USD
-1.68%
FAQ

Is InfuSystem Holdings Inc (INFU) currently overvalued or undervalued?
InfuSystem Holdings Inc (INFU) is now in the Fair zone, suggesting that its current forward PE ratio of 36.42 is considered Fairly compared with the five-year average of 81.03. The fair price of InfuSystem Holdings Inc (INFU) is between 1.94 to 20.00 according to relative valuation methord.

What is InfuSystem Holdings Inc (INFU) fair value?

How does INFU's valuation metrics compare to the industry average?

What is the current P/B ratio for InfuSystem Holdings Inc (INFU) as of Jul 28 2025?

What is the current FCF Yield for InfuSystem Holdings Inc (INFU) as of Jul 28 2025?

What is the current Forward P/E ratio for InfuSystem Holdings Inc (INFU) as of Jul 28 2025?
